The application prospect of targeting TRM cells is broad, including methods to increase TRM cell numbers within solid tumors using therapeutic vaccines [86], and PD‐L1 blockade to reduce TRM cell apoptosis, which has been demonstrated in several animal studies aimed at controlling tumor progression. This evidence concerns the gene CD274 and neoplasm.